JCX-8-23 (May 09, 2023)

Present Law And Economic Background Relating To Pharmaceutical Manufacturers And U.S. International Tax Policy

The Senate Committee on Finance has scheduled a public hearing on May 11, 2023, titled “Cross-border Rx: Pharmaceutical Manufacturers and U.S. International Tax Policy.”  The staff of the Joint Committee on Taxation has prepared a document that describes legal and economic background on U.S. taxation of U.S. multinational corporations and their cross-border activities.

 

Related Publications

  • JCX-6-24 (January 24, 2024)

    Macroeconomic Analysis Of H.R. 7024, The "Tax Relief For American Families And Workers Act of 2024," As Ordered Reported By The Committee on Ways And Means, On January 19, 2024

    view details
  • JCX-5-24 (January 18, 2024)

    Estimated Revenue Effects Of The Chairman's Amendment In The Nature Of A Substitute To H.R. 7024, The "Tax Relief For American Families And Workers Act of 2024," Scheduled For Markup By The Committee On Ways And Means on January 19, 2024

    view details
  • JCX-4-24 (January 18, 2024)

    Description Of The Chairman's Amendment In The Nature Of A Substitute To H.R. 7024, The "Tax Relief For American Families And Workers Act of 2024"

    view details